Search

everythinglearnresearchcommunity

for

Search:↓

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Using platelet-rich plasma in hair restoration surgery significantly improves hair density after 6 months and is safe to use.

The R343H mutation in the VDR gene causes vitamin D-resistant rickets with alopecia by impairing specific gene activity.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Advancements in creating skin grafts with biomaterials and stem cells are promising, but more research is needed for clinical application.

Adipose-derived stem cells show potential for skin rejuvenation and wound healing but require more research to overcome challenges and ensure safety.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Twist1 helps maintain important features of cells crucial for hair growth by working with Tcf4 and β-catenin.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Acupressure improves quality of life in PCOS patients.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

A systematic approach is crucial for managing hair loss in women.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Home-use cosmetic laser and light devices show modest results for hair removal and acne treatment, but more research is needed for confirmation.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Researchers created a reliable method to detect hair-growth substances in products.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Scientists developed a new method to deliver alopecia treatment directly to hair follicles, which could be a promising treatment for hair loss and other hair diseases.